Science
Orforglipron Trial Shows 8% Weight Loss as Oral GLP-1 Alternative Gains Ground
A clinical trial published in The Lancet reveals that the experimental daily pill orforglipron can help patients lose up to 8% of their body weight. The drug, manufactured by Eli Lilly, offers a potential needle-free alternative to current blockbuster weight-loss injections.
February 26, 2026459 views
Score-1
Enjoyed this story? Share it! 👇
Advertisement
Related Stories
Science
Curiosity Rover Uncovers Mysterious 'Egg-Like' Structures Within Martian 'Spiderwebs'
1d ago
Science
The Iron Paradox: How Earth’s First Oxygen Producers Overcame Toxic Oceans
1d ago
Science
Forensic Science Breakthrough: Why Crime Scene Blood Stains Persist After Cleaning
1d ago
Science
Scientists Develop Vitamin A-Enriched Tomato to Combat Global Nutritional Deficiencies
1d ago
Comments (0)
Sign in to leave a comment.
No comments yet. Be the first to share your thoughts!